CytoJournal,
Journal Year:
2024,
Volume and Issue:
21, P. 46 - 46
Published: Nov. 19, 2024
Epithelial-mesenchymal
transition
(EMT)
and
metastasis
are
the
primary
causes
of
mortality
in
non-small-cell
lung
cancer
(NSCLC).
5'-3'
exoribonuclease
2
(XRN2)
plays
an
important
role
process
tumor
EMT.
Thus,
this
investigation
mainly
aimed
to
clarify
precise
molecular
pathways
through
which
XRN2
contributes
EMT
NSCLC.
FEBS Letters,
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 6, 2024
Recently,
there
has
been
increasing
interest
in
the
complex
relationship
between
transcription
and
genome
stability,
with
specific
attention
directed
toward
physiological
significance
of
molecular
structures
known
as
R‐loops.
These
arise
when
an
RNA
strand
invades
into
DNA
duplex,
their
formation
is
involved
a
wide
range
regulatory
functions
affecting
gene
expression,
repair
processes
or
cell
homeostasis.
The
persistent
presence
R‐loops,
if
not
effectively
removed,
contributes
to
instability,
underscoring
factors
responsible
for
resolution
modification.
In
this
review,
we
provide
comprehensive
overview
how
R‐loop
processing
can
drive
either
beneficial
harmful
outcome.
Additionally,
explore
potential
manipulating
such
devise
rationalized
therapeutic
strategies
targeting
aberrant
accumulation
Cell Reports,
Journal Year:
2025,
Volume and Issue:
44(1), P. 115142 - 115142
Published: Jan. 1, 2025
Highlights•TKT
attenuates
the
chemosensitivity
in
glioma
independent
of
catalytic
activity•Chemotherapeutic
drugs
promote
TKT's
nuclear
translocation
cells•TKT
interacts
with
XRN2
to
regulate
resolution
and
removal
R-loopsSummaryGlioblastoma
(GBM)
is
a
highly
lethal
malignant
brain
tumor
poor
survival
rates,
chemoresistance
poses
significant
challenge
treatment
patients
GBM.
Here,
we
show
that
transketolase
(TKT),
metabolic
enzyme
pentose
phosphate
pathway
(PPP),
chemotherapy
sensitivity
cells
manner
activity.
Mechanistically,
chemotherapeutic
can
facilitate
TKT
protein
from
cytosol
into
nucleus,
where
physically
R-loops.
Depletion
leads
increased
R-loop
accumulation
genome
instability,
increasing
susceptibility
chemotherapy.
In
conclusion,
our
study
reveals
non-metabolic
function
regulating
dynamics,
gliomas.Graphical
abstract
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 6, 2025
DNA-RNA
hybrids
triggered
by
double-strand
breaks
(DSBs)
are
crucial
intermediates
during
DSB
repair,
and
their
timely
resolution
requires
numbers
of
RNA
helicases,
including
DEAD
box
1
(DDX1).
However,
how
these
helicases
recruited
to
DSB-induced
in
time
remains
largely
unclear.
Here,
we
revealed
that
squamous
cell
carcinoma
antigen
recognized
T
cells
3
(SART3)
promotes
DDX1
binding
at
DSBs
for
optimal
homologous
recombination
(HR)
repair.
SART3
itself
associates
with
PAR
chains
accumulates
both
PARylation-
hybrids-dependent
fashion.
also
is
necessary
enrichment
DSBs.
The
defective
SART3-DDX1
association
observed
expressing
the
cancer-associated
variant
SART3-R836W
impairs
not
only
accumulation
DDX1,
but
hybrid
removal
HR
efficiency.
Moreover,
DNA
end
resection
through
enhancing
USP15-BARD1
BRCA1-BARD1
retention.
Together,
our
study
reveals
an
role
rendering
a
promising
target
cancer
therapy.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(6), P. 2405 - 2405
Published: March 7, 2025
The
DNA
damage
response
(DDR)
is
crucial
for
maintaining
genomic
stability
and
preventing
the
accumulation
of
mutations
that
can
lead
to
various
diseases,
including
cancer.
DDR
a
complex
cellular
regulatory
network
involves
sensing,
signal
transduction,
repair,
cell
cycle
arrest.
Modifications
in
histone
phosphorylation
play
important
roles
these
processes,
facilitating
repair
factor
recruitment,
chromatin
remodeling,
regulation.
precise
regulation
critical
effective
damage,
integrity
maintenance,
prevention
diseases
such
as
cancer,
where
mechanisms
are
often
compromised.
Thus,
understanding
provides
insights
into
offers
potential
therapeutic
targets
associated
with
instability,
cancers.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 29, 2025
Abstract
Homologous
recombination
repair
(HRR)
is
crucial
for
maintaining
genomic
stability
by
repairing
DNA
damage.
Despite
its
importance,
HRR's
role
in
cancer
progression
not
fully
elucidated.
Here,
this
work
shows
that
nuclear‐localized
branched‐chain
α‐ketoacid
dehydrogenase
kinase
(BCKDK)
acts
as
a
modulator
of
HRR,
promoting
cell
resistance
against
damage‐inducing
therapy
breast
cancer.
Mechanistically,
demonstrates
BCKDK
localized
the
nucleus
and
phosphorylates
RNF8
at
Ser157,
preventing
ubiquitin‐mediated
degradation
RAD51,
thereby
facilitating
HRR‐mediated
under
replication
stress.
Notably,
aberrant
expression
BCKDK/p‐RNF8/RAD51
axis
correlates
with
poor
patient
survival.
Furthermore,
identifies
small
molecule
inhibitor
BCKDK,
GSK180736A,
disrupts
HRR
function
exhibits
strong
tumor
suppression
when
combined
drugs.
Collectively,
study
reveals
new
regulating
independent
metabolic
function,
presenting
it
potential
therapeutic
target
predictive
biomarker
Cancers,
Journal Year:
2024,
Volume and Issue:
16(3), P. 595 - 595
Published: Jan. 30, 2024
R-loops
(RNA–DNA
hybrids
with
displaced
single-stranded
DNA)
have
emerged
as
a
potent
source
of
DNA
damage
and
genomic
instability.
The
termination
defective
RNA
polymerase
II
(RNAPII)
is
one
the
major
sources
R-loop
formation.
5′-3′-exoribonuclease
2
(XRN2)
promotes
genome-wide
efficient
RNAPII
termination,
XRN2-deficient
cells
exhibit
increased
emanating
from
elevated
R-loops.
Recently,
we
showed
that
instigated
by
XRN2
depletion
in
human
fibroblast
resulted
enhanced
poly(ADP-ribose)
1
(PARP1)
activity.
Additionally,
established
synthetic
lethal
relationship
between
PARP1.
However,
underlying
cellular
stress
response
promoting
this
lethality
remains
elusive.
Here,
delineate
molecular
consequences
leading
to
cancer
induced
PARP
inhibition.
We
found
lung
breast
display
sensitivity
two
clinically
relevant
inhibitors,
Rucaparib
Olaparib.
At
mechanistic
level,
inhibition
combined
deficiency
exacerbates
double-strand
break
formation
cells.
Consistent
our
previous
findings
using
several
different
siRNAs,
also
show
hyperactivates
Furthermore,
observed
replication
treated
inhibitors.
Finally,
compromised
PARP1
catalytic
function
activates
caspase-3
initiate
cell
death.
Collectively,
these
provide
insights
into
strengthen
translational
implications
for
targeted
therapy.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Nov. 6, 2024
Ribosomal
DNA
(rDNA)
repeats
harbor
ribosomal
RNA
(rRNA)
genes
and
intergenic
spacers
(IGS).
polymerase
(Pol)
I
transcribes
rRNA
yielding
components
of
ribosomes.
IGS-associated
Pol
II
prevents
from
excessively
synthesizing
IGS
non-coding
RNAs
(ncRNAs)
that
can
disrupt
nucleoli
production.
Here,
compartment-enriched
proximity-dependent
biotin
identification
(compBioID)
revealed
the
TATA-less-promoter-binding
TBPL1
transcription-regulatory
PAF1
with
nucleolar
II.
localizes
to
TCT
motifs,
driving
maintaining
its
baseline
ncRNA
levels.
promotes
elongation,
preventing
unscheduled
R-loops
hyper-restrain
I-associated
ncRNAs.
or
deficiency
disrupts
organization
biogenesis.
In
PAF1-deficient
cells,
repressing
rescues
Depleting
I-dependent
ncRNAs
is
sufficient
compromise
nucleoli.
We
present
interactome
show
regulation
by
ensures
structure
function.
By
revealing
II,
authors
transcription
within
DNA's
levels
critical
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 10, 2023
Abstract
Nucleolar
ribosomal
DNA
(rDNA)
repeats
control
ribosome
manufacturing.
rDNA
harbors
a
RNA
(rRNA)
gene
and
an
intergenic
spacer
(IGS).
polymerase
(Pol)
I
transcribes
rRNA
genes
yielding
the
components
of
ribosomes.
Pol
II
at
IGS
induces
production
by
preventing
from
excessively
synthesizing
non-coding
RNAs
(ncRNAs)
that
can
disrupt
nucleoli.
At
IGS,
regulatory
processes
whether
function
be
beneficial
remain
unknown.
Here,
we
identify
regulators,
uncovering
nucleolar
optimization
via
I.
Compartment-enriched
proximity-dependent
biotin
identification
(compBioID)
showed
enrichment
TATA-less
promoter-binding
TBPL1
transcription
regulator
PAF1
with
II.
localizes
to
TCT
motifs,
driving
maintaining
its
baseline
ncRNA
levels.
promotes
elongation,
unscheduled
R-loops
hyper-restrain
ncRNAs.
or
deficiency
disrupts
organization
biogenesis.
In
PAF1-deficient
cells,
repressing
rescues
production.
Depleting
I-dependent
ncRNAs
is
sufficient
compromise
We
present
interactome
show
ensures
structure
operation.